Lit Matters 3: Does order of antibiotics matter?

In suspected sepsis, the first antibiotic may matter as much as the clock. When empiric therapy includes both vancomycin and a broad-spectrum beta-lactam, giving the beta-lactam first was associated with lower in-hospital mortality and avoided a meaningful delay in definitive gram-negative coverage.

Antibiotic Sequence in Suspected Sepsis

• Beta-lactam first principle: Broad-spectrum beta-lactams should start before vancomycin in suspected sepsis, because the sequence was associated with lower in-hospital mortality in a 25,000-patient multicenter cohort.
• Infusion-time penalty: Vancomycin-first created a real timing cost: beta-lactam administration landed about 3 hours later, reinforcing that a long infusion can quietly delay the drug doing the early sepsis work.
• Mortality signal size: The adjusted mortality advantage favored beta-lactam first with an 11% lower odds of death, a clinically credible effect even after accounting for illness severity and site differences.
• Shock versus no-shock pattern: The association was strongest in sepsis without shock, while the septic shock subgroup did not show a clear mortality separation. We get into why that signal may differ in the episode.
• MRSA coverage nuance: Giving vancomycin first did not show a survival advantage even in patients with MRSA clinical cultures, underscoring that immediate MRSA coverage is not the same as vancomycin needing to hang first.
• Protocol-level implication: This is a systems issue more than a bedside pearl: order sets, nurse workflow, and pharmacy timing should make beta-lactam-first the default when both agents are planned. We walk through the operational implications in the chapter.